These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 1690838

  • 1. The peculiar difficulties of therapeutic trials for multiple sclerosis.
    Myers LW, Ellison GW.
    Neurol Clin; 1990 Feb; 8(1):119-41. PubMed ID: 1690838
    [Abstract] [Full Text] [Related]

  • 2. Multiple sclerosis. II. A critical assessment of immunotherapy.
    Durelli L, Bergamini L.
    Riv Neurol; 1989 Feb; 59(5):191-201. PubMed ID: 2483962
    [Abstract] [Full Text] [Related]

  • 3. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.
    Goodkin DE.
    West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G, Antonello RM, Zorzon M, Torre P, Zivadinov R, Moretti R, Bragadin LM, De Masi R, Nasuelli D.
    Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
    [Abstract] [Full Text] [Related]

  • 5. Immunotherapeutics of multiple sclerosis.
    Durelli L.
    Acta Neurol (Napoli); 1991 Oct; 13(5):467-75. PubMed ID: 1723242
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH.
    Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
    [Abstract] [Full Text] [Related]

  • 7. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC, Hartung HP.
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [Abstract] [Full Text] [Related]

  • 8. [Is immunosuppression a future therapeutic strategy for multiple sclerosis?].
    Edan G, Coustans M.
    Pathol Biol (Paris); 2000 Mar; 48(2):114-20. PubMed ID: 10815287
    [Abstract] [Full Text] [Related]

  • 9. [Combined therapy in multiple sclerosis].
    García-Merino JA, Blasco-Quítez MR, Ortiz-Benítez P, Puerta C.
    Rev Neurol; 2000 Mar; 36(6):545-9. PubMed ID: 12652419
    [Abstract] [Full Text] [Related]

  • 10. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B, Sørensen PS.
    Ugeskr Laeger; 1994 Oct 24; 156(43):6353-8. PubMed ID: 7810008
    [Abstract] [Full Text] [Related]

  • 11. [Significance of neutralizing antibodies to immunomodulatory therapy and their laboratory analysis in multiple sclerosis].
    Seres E, Vécsei L.
    Ideggyogy Sz; 2006 May 20; 59(5-6):156-62. PubMed ID: 16786710
    [Abstract] [Full Text] [Related]

  • 12. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T, Bereczki D.
    Ideggyogy Sz; 2004 Nov 20; 57(11-12):401-16. PubMed ID: 15662768
    [Abstract] [Full Text] [Related]

  • 13. Medications used in the treatment of multiple sclerosis.
    Schapiro RT.
    Phys Med Rehabil Clin N Am; 1999 May 20; 10(2):437-46, ix. PubMed ID: 10370939
    [Abstract] [Full Text] [Related]

  • 14. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL, Fosburg M, Kevy S, Weiner HL.
    Prog Clin Biol Res; 1982 May 20; 106():239-54. PubMed ID: 6184727
    [Abstract] [Full Text] [Related]

  • 15. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O, Fernández V, De Ramón E.
    J Neurol Sci; 2004 Aug 15; 223(1):29-34. PubMed ID: 15261557
    [Abstract] [Full Text] [Related]

  • 16. Natalizumab: new drug. Multiple sclerosis: risky market approval.
    Prescrire Int; 2008 Feb 15; 17(93):7-10. PubMed ID: 18354844
    [Abstract] [Full Text] [Related]

  • 17. Non-specific immunosuppressants in the treatment of multiple sclerosis.
    Confavreux C, Vukusic S.
    Clin Neurol Neurosurg; 2004 Jun 15; 106(3):263-9. PubMed ID: 15177781
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive treatment of multiple sclerosis.
    Carter JL, Rodriguez M.
    Mayo Clin Proc; 1989 Jun 15; 64(6):664-9. PubMed ID: 2473360
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy in multiple sclerosis, Part 1.
    Becker CC, Gidal BE, Fleming JO.
    Am J Health Syst Pharm; 1995 Sep 15; 52(18):1985-2000. PubMed ID: 8528866
    [Abstract] [Full Text] [Related]

  • 20. [Immunosuppressive medication in multiple sclerosis].
    García Merino JA.
    Rev Neurol; 1995 Sep 15; 35(12):1154-8. PubMed ID: 12497298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.